Health
Safety in mind as Prescient Therapeutics develops next-generation CAR-T platform – Stockhead
Tragedy struck the CAR-T space this month with a US company halting a trial of its lead therapy after the deaths of two patients….
Link copied toclipboard
Tragedy struck the CAR-T space this month with a US company halting a trial of its lead therapy after the deaths of two patients, a sobering reminder of the dangers involved in cell therapy.
The patients reportedly died from immune…
Continue Reading